---
figid: PMC7346528__nihms-1596987-f0001
figlink: pmc/articles/PMC7346528/figure/F1/
number: F1
caption: Hedgehog signaling pathway. Initial ligand binding activates hedgehog signaling.
  Sonic hedgehog binds to the receptor PTCH1, which disrupts the inhibition of cytoplasmic
  smoothened, allowing it to translocate to the membrane where it is active. Membrane-bound
  smoothened then activates SUFU, which facilitates the translocation of GLI1–3 into
  the nucleus. Once in the nucleus, the GLI1–3 transcription factors coordinate the
  expression of numerous genes. Due to its involvement in numerous sporadic tumor
  types, inhibitors of the Hh pathway activity have been developed. The two main targets
  of inhibition are smoothened and GLI1. The main inhibitors are labeled in red
pmcid: PMC7346528
papertitle: Mutations in the sonic hedgehog pathway cause macrocephaly-associated
  conditions due to crosstalk to the PI3K/AKT/mTOR pathway.
reftext: Steven D. Klein, et al. Am J Med Genet A. ;179(12):2517-2531.
pmc_ranked_result_index: '28068'
pathway_score: 0.9716892
filename: nihms-1596987-f0001.jpg
figtitle: Hedgehog signaling pathway
year: ''
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7346528__nihms-1596987-f0001.html
  '@type': Dataset
  description: Hedgehog signaling pathway. Initial ligand binding activates hedgehog
    signaling. Sonic hedgehog binds to the receptor PTCH1, which disrupts the inhibition
    of cytoplasmic smoothened, allowing it to translocate to the membrane where it
    is active. Membrane-bound smoothened then activates SUFU, which facilitates the
    translocation of GLI1–3 into the nucleus. Once in the nucleus, the GLI1–3 transcription
    factors coordinate the expression of numerous genes. Due to its involvement in
    numerous sporadic tumor types, inhibitors of the Hh pathway activity have been
    developed. The two main targets of inhibition are smoothened and GLI1. The main
    inhibitors are labeled in red
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - SHH
  - IHH
  - PTCH2
  - PTCH1
  - GLI1
  - GLI2
  - GLI3
  - SUFU
  - KIF7
  - DYRK1A
  - Cyclopamine
  - Saridegib
  - CUR61414
  - BMS-833923
  - PF-5274857
  - ATO
genes:
- word: SHH
  symbol: SHH
  source: hgnc_symbol
  hgnc_symbol: SHH
  entrez: '6469'
- word: IHH
  symbol: IHH
  source: hgnc_symbol
  hgnc_symbol: IHH
  entrez: '3549'
- word: PTCH1/2
  symbol: PTCH2
  source: hgnc_symbol
  hgnc_symbol: PTCH2
  entrez: '8643'
- word: PTCH1/2
  symbol: PTCH1
  source: hgnc_symbol
  hgnc_symbol: PTCH1
  entrez: '5727'
- word: GLI-1
  symbol: GLI1
  source: hgnc_symbol
  hgnc_symbol: GLI1
  entrez: '2735'
- word: GLI-2
  symbol: GLI2
  source: hgnc_symbol
  hgnc_symbol: GLI2
  entrez: '2736'
- word: GLI-3
  symbol: GLI3
  source: hgnc_symbol
  hgnc_symbol: GLI3
  entrez: '2737'
- word: SUFU
  symbol: SUFU
  source: hgnc_symbol
  hgnc_symbol: SUFU
  entrez: '51684'
- word: KIF7
  symbol: KIF7
  source: hgnc_symbol
  hgnc_symbol: KIF7
  entrez: '374654'
- word: GLI-1
  symbol: GLI1
  source: hgnc_symbol
  hgnc_symbol: GLI1
  entrez: '2735'
- word: GLI-2
  symbol: GLI2
  source: hgnc_symbol
  hgnc_symbol: GLI2
  entrez: '2736'
- word: DYRK1A
  symbol: DYRK1A
  source: hgnc_symbol
  hgnc_symbol: DYRK1A
  entrez: '1859'
- word: GLI-3
  symbol: GLI3
  source: hgnc_symbol
  hgnc_symbol: GLI3
  entrez: '2737'
chemicals:
- word: Cyclopamine
  source: MESH
  identifier: C000541
- word: Saridegib
  source: MESH
  identifier: C541444
- word: CUR61414
  source: MESH
  identifier: C474318
- word: BMS-833923
  source: MESH
  identifier: C583051
- word: PF-5274857
  source: MESH
  identifier: C573117
- word: ATO
  source: MESH
  identifier: C553022
diseases: []
figid_alias: PMC7346528__F1
redirect_from: /figures/PMC7346528__F1
figtype: Figure
---
